 Connection
Tyler Buckner to Humans
This is a "connection" page, showing publications Tyler Buckner has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.456 |
|
|
|
-
Buckner TW, Carpenter SL, Daoud N, Kempton CL, Lee L, Malec L, McLean TW, Morton P, O'Neill C, Staber JM, Wang M, Croteau SE, Recht M. Safety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History Study. Haemophilia. 2026 Jan-Feb; 32(1):63-70.
Score: 0.023
-
Buckner TW, Kessler C, Castaman G, Hermans C, Jiménez-Yuste V, Mahlangu J, Miesbach W, Oldenburg J, Recht M, Valentino LA, Wheeler AP, Pipe SW. Pain Reduction Following Eptacog Beta Treatment of Bleeding Episodes in Adolescents and Adults With Haemophilia A or B Complicated by Inhibitors. Haemophilia. 2025 Jul; 31(4):713-721.
Score: 0.022
-
Hermans C, Skinner MW, Gentile B, Lim E, Minhas M, Moreno K, Tzeng E, Buckner TW. Pain-Related Quality of Life Outcomes in People With Haemophilia A Receiving Emicizumab: A Post Hoc Analysis of the HAVEN 1, 3 and 4 and STASEY Studies. Haemophilia. 2025 Jan; 31(1):87-98.
Score: 0.022
-
Byams VR, Baker JR, Bailey C, Connell NT, Creary MS, Curtis RG, Dinno A, Guelcher CJ, Kim M, Kulkarni R, Lattimore S, Norris KL, Ramirez L, Skinner MW, Symington S, Tobase P, Vázquez E, Warren BB, Wheat E, Buckner TW. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science. Expert Rev Hematol. 2023 03; 16(sup1):87-106.
Score: 0.019
-
Newman JR, Durben N, Baumann K, Lambing AY, Nichols CD, Witkop M, Santaella ME, Buckner TW. Physical therapy within US HTCs: A multicentre survey of utilization, practice patterns and pain management approaches. Haemophilia. 2022 Mar; 28(2):343-350.
Score: 0.018
-
Kleiboer B, Layer MA, Cafuir LA, Cuker A, Escobar M, Eyster ME, Kraut E, Leavitt AD, Lentz SR, Quon D, Ragni MV, Thornhill D, Wang M, Key NS, Buckner TW. Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study. J Thromb Haemost. 2022 04; 20(4):857-865.
Score: 0.018
-
Witkop M, Santaella M, Nichols CD, Lambing AY, Baumann K, Curtis RG, Humphrey C, Humphries TJ, Newman J, Durben N, Fritz R, Mauer K, Thibodeaux CB, Wheat E, Buckner T. Understanding the Pain Management Landscape Within the US Bleeding Disorder Community: A Multi-Center Survey. Pain Med. 2022 02 01; 23(2):269-279.
Score: 0.018
-
Buckner TW, Bocharova I, Hagan K, Bensimon AG, Yang H, Wu EQ, Sawyer EK, Li N. Health care resource utilization and cost burden of hemophilia B in the United States. Blood Adv. 2021 04 13; 5(7):1954-1962.
Score: 0.017
-
Lim MY, Buckner TW. Nonsevere hemophilia A: often overlooked, but not forgotten. Curr Opin Hematol. 2020 09; 27(5):295-301.
Score: 0.016
-
Soucie JM, Miller CH, Dupervil B, Le B, Buckner TW. Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres. Haemophilia. 2020 May; 26(3):487-493.
Score: 0.016
-
Buckner TW, Watson C, Recht M. Emicizumab in Hemophilia A. N Engl J Med. 2020 02 20; 382(8):785-786.
Score: 0.016
-
Buckner TW, Sidonio R, Guelcher C, Kessler CM, Witkop M, Clark D, Owens W, Fridman M, Iyer NN, Cooper DL. Reliability and validity of patient-reported outcome instruments in US adults with hemophilia B and caregivers in the B-HERO-S study. Eur J Haematol. 2018 Dec; 101(6):781-790.
Score: 0.014
-
Buckner TW, Witkop M, Guelcher C, Sidonio R, Kessler CM, Clark DB, Owens W, Frick N, Iyer NN, Cooper DL. Impact of hemophilia B on quality of life in affected men, women, and caregivers-Assessment of patient-reported outcomes in the B-HERO-S study. Eur J Haematol. 2018 Jun; 100(6):592-602.
Score: 0.014
-
Buckner TW, Batt K, Quon D, Witkop M, Recht M, Kessler C, Baumann K, Hernandez G, Wang M, Cooper DL, Kempton CL. Assessments of pain, functional impairment, anxiety, and depression in US adults with hemophilia across patient-reported outcome instruments in the Pain, Functional Impairment, and Quality of Life (P-FiQ) study. Eur J Haematol. 2018 Apr; 100 Suppl 1:5-13.
Score: 0.014
-
Buckner TW, Batt K, Cooper DL, Kempton CL. What can we learn from using formal patient-reported outcome instruments to assess pain, functional impairment, anxiety, and depression in US adults with hemophilia? Eur J Haematol. 2018 Apr; 100 Suppl 1:3-4.
Score: 0.014
-
Buckner TW, Witkop M, Guelcher C, Frey MJ, Hunter S, Peltier S, Recht M, Walsh C, Kessler CM, Owens W, Clark DB, Frick N, Rice M, Iyer NN, Holot N, Cooper DL, Sidonio R. Management of US men, women, and children with hemophilia and methods and demographics of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study. Eur J Haematol. 2017 Apr; 98 Suppl 86:5-17.
Score: 0.013
-
Buckner TW, Leavitt AD, Ragni M, Kempton CL, Eyster ME, Cuker A, Lentz SR, Ducore J, Leissinger C, Wang M, Key NS. Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thromb Haemost. 2016 07 04; 116(1):42-9.
Score: 0.012
-
Buckner TW, Nielsen BI, Key NS, Ma A. Factor VIII inhibitory antibody in a patient with combined factor V/factor VIII deficiency. Haemophilia. 2015 Jan; 21(1):e77-80.
Score: 0.011
-
Buckner TW, Ataga KI. Does hydroxyurea prevent pulmonary complications of sickle cell disease? Hematology Am Soc Hematol Educ Program. 2014 Dec 05; 2014(1):432-7.
Score: 0.011
-
Buckner TW, Wang J, DeWalt DA, Jacobs S, Reeve BB, Hinds PS. Patterns of symptoms and functional impairments in children with cancer. Pediatr Blood Cancer. 2014 Jul; 61(7):1282-8.
Score: 0.010
-
Buckner TW, Dunphy C, Fedoriw YD, van Deventer HW, Foster MC, Richards KL, Park SI. Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections. Clin Lymphoma Myeloma Leuk. 2012 Dec; 12(6):455-8.
Score: 0.009
-
Buckner TW, Key NS. Venous thrombosis in blacks. Circulation. 2012 Feb 14; 125(6):837-9.
Score: 0.009
-
Buckner TW, Amin C, Esserman DA, Key NS. African-Americans have a higher rate of proximal deep vein thrombosis at presentation. Thromb Res. 2010 Sep; 126(3):e246-7.
Score: 0.008
-
Buckner T, Blatt J, Smith SV. The autopsy in pediatrics and pediatric oncology: a single-institution experience. Pediatr Dev Pathol. 2006 Sep-Oct; 9(5):374-80.
Score: 0.006
-
Johnsen JM, Buckner TW, Batsuli G, Carlson SA, Burke Cirelli E, DiMichele D, Flood VH, Johnson AD, Heiman M, Kaplan J, Konkle BA, Khor B, Lankau EW, Levy GG, Norris KL, Pierce GF, Popp NA, Recht M, Roberts JC, Robinson F, Santaella ME, Shavit JA, Stanhope RW, Valadez S, Witkop ML, Malec L, Shapiro AD. Research agenda and related workforce requirements inspired by Lived Experience Experts and grounded in health equity for the Bleeding Disorders Research Collaborative. Expert Rev Hematol. 2026 Jul; 19(sup1):63-79.
Score: 0.006
-
Fedewa SA, Buckner TW, Cafuir L, Sidonio RF, Lim M, Kempton CL. Approaches to Identify People With Haemophilia With Medicare Claims Data. Haemophilia. 2026 Mar-Apr; 32(2):410-417.
Score: 0.006
-
Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, Fertrin KY, Fogerty AE, Crestani NG, Gangaraju R, Rojas-Hernandez C, Goldhaber SZ, Ibrahim I, Kubal T, Leavitt AD, Lim M, Mann J, Mantha S, Morton C, Nester A, O'Brien A, Ortel TL, Pine A, Pishko A, Ranade M, Salmasi A, Schaefer J, Williams E, Wool G, Wun T, Montgomery S, Nguyen J, Freedman-Cass D, Sliker B. Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 09; 22(7):483-506.
Score: 0.005
-
Kempton CL, Guasch SA, Buckner TW, Mattis S, Fedewa SA. Differences and similarities in patient-reported outcomes among men and women with haemophilia. Haemophilia. 2024 Nov; 30(6):1383-1392.
Score: 0.005
-
Itzler R, Buckner TW, Leebeek FWG, Miller J, Recht M, Drelich D, Monahan PE, Pipe SW. Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapy. Haemophilia. 2024 May; 30(3):709-719.
Score: 0.005
-
Schreiber AR, Santos J, McMahon B, Buckner TW, Olson C, Alberti MO, Guimarães-Young A, Knoeckel C, Broussard L, Aubrey M, Palmer BE, Weiss E, Connors GR, Brunner S, Wisell JA, Pacheco T, Aisner DL, Gutman JA. A Case of Fetal-Induced Graft-versus-Host Disease. N Engl J Med. 2023 08 17; 389(7):668-670.
Score: 0.005
-
Astermark J, Buckner TW, Frenzel L, Hatswell AJ, You X, Liu H, Goodman E, Santos S, Hawes C, Hinds D, Klamroth R. Matching-adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxis. Haemophilia. 2023 Jul; 29(4):1087-1094.
Score: 0.005
-
Fedewa SA, Buckner TW, Parks SG, Tran DQ, Cafuir L, Antun AG, Mattis S, Kempton CL. Racial and Ethnic Differences in Distress, Depression, and Quality of Life in people with hemophilia. J Racial Ethn Health Disparities. 2024 06; 11(3):1394-1404.
Score: 0.005
-
Guasch S, Scott LC, Figueroa J, Buckner TW, Mattis S, Tran DQ, Kempton CL. Cross-sectional study evaluating the association of haemophilia-related distress and clinically relevant outcomes. Haemophilia. 2023 Mar; 29(2):505-512.
Score: 0.005
-
Kuijlaars IAR, van der Net J, Buckner TW, Kempton CL, Schutgens REG, Fischer K. Shortening the Haemophilia Activities List (HAL) from 42 items to 18 items. Haemophilia. 2021 Nov; 27(6):1062-1070.
Score: 0.004
-
Miller CH, Soucie JM, Byams VR, Payne AB, Sidonio RF, Buckner TW, Bean CJ. Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States. Haemophilia. 2021 Nov; 27(6):1037-1044.
Score: 0.004
-
Witkop M, Morgan G, O'Hara J, Recht M, Buckner TW, Nugent D, Curtis R, O'Mahony B, Skinner MW, Mulhern B, Cawson M, Ali TM, Sawyer EK, Li N. Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment. Haemophilia. 2021 Sep; 27(5):769-782.
Score: 0.004
-
Ng CJ, Spomer N, Shearer R, LeBlanc A, Funk S, Manco-Johnson M, Branchford B, Warren B, Buckner TW, Cowell A, Moyer G, Wang M, Gibson E, Mashburn C. Improvements in Communication and Coordination of Care in a Hemophilia Treatment Center. Acta Haematol. 2021; 144(6):672-677.
Score: 0.004
-
Barry V, Buckner TW, Lynch ME, Figueroa J, Mattis S, Stout ME, Kempton CL. An evaluation of PROMIS health domains in adults with haemophilia: A cross-sectional study. Haemophilia. 2021 May; 27(3):375-382.
Score: 0.004
-
O'Hara J, Martin AP, Nugent D, Witkop M, Buckner TW, Skinner MW, O'Mahony B, Mulhern B, Morgan G, Li N, Sawyer EK. Evidence of a disability paradox in patient-reported outcomes in haemophilia. Haemophilia. 2021 Mar; 27(2):245-252.
Score: 0.004
-
Manco-Johnson MJ, Warren BB, Buckner TW, Funk SM, Wang M. Outcome measures in Haemophilia: Beyond ABR (Annualized Bleeding Rate). Haemophilia. 2021 Feb; 27 Suppl 3:87-95.
Score: 0.004
-
Kempton CL, Michaels Stout M, Barry V, Figueroa J, Buckner TW, Gillespie S, Ellen Lynch M, Mattis S, Whitten S, McCracken C. Validation of a new instrument to measure disease-related distress among patients with haemophilia. Haemophilia. 2021 Jan; 27(1):60-68.
Score: 0.004
-
Maher KN, Gibson E, Warren BB, Funk SM, Shearer R, Buckner TW, Wang M, Manco-Johnson MJ, Ng CJ. Prophylaxis for children with moderate hemophilia: Use of a guideline to increase early initiation. Pediatr Blood Cancer. 2021 01; 68(1):e28577.
Score: 0.004
-
Asher ZP, Buckner TW, McIntyre RC. Postoperative hemorrhage secondary to acquired hemophilia A. JAAPA. 2020 Jun; 33(6):24-26.
Score: 0.004
-
Kempton CL, Buckner TW, Fridman M, Iyer NN, Cooper DL. Factors associated with pain severity, pain interference, and perception of functional abilities independent of joint status in US adults with hemophilia: Multivariable analysis of the Pain, Functional Impairment, and Quality of Life (P-FiQ) study. Eur J Haematol. 2018 Apr; 100 Suppl 1:25-33.
Score: 0.003
-
Batt K, Boggio L, Neff A, Buckner TW, Wang M, Quon D, Witkop M, Recht M, Kessler C, Iyer NN, Cooper DL. Patient-reported outcomes and joint status across subgroups of US adults with hemophilia with varying characteristics: Results from the Pain, Functional Impairment, and Quality of Life (P-FiQ) study. Eur J Haematol. 2018 Apr; 100 Suppl 1:14-24.
Score: 0.003
-
Kempton CL, Recht M, Neff A, Wang M, Buckner TW, Soni A, Quon D, Witkop M, Boggio L, Gut RZ, Cooper DL. Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study. Haemophilia. 2018 Mar; 24(2):261-270.
Score: 0.003
-
Witkop M, Neff A, Buckner TW, Wang M, Batt K, Kessler CM, Quon D, Boggio L, Recht M, Baumann K, Gut RZ, Cooper DL, Kempton CL. Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study. Haemophilia. 2017 Jul; 23(4):556-565.
Score: 0.003
-
Lim MY, Buckner TW, Kasthuri RS, Ma AD, Key NS. Management of adult non-severe haemophilia A patients with inhibitors: a practice-pattern survey. Haemophilia. 2015 Sep; 21(5):e422-4.
Score: 0.003
-
Ishaku NG, Key NS, Miller CH, Nielsen B, Buckner T, Chen SL, Hooper WC, Soucie JM. Cluster of inhibitors among adult inpatients with haemophilia in a single institution. Haemophilia. 2015 Jul; 21(4):e325-8.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|